SDK licensing for every stage.

A device seat is one deployed rehabilitation device (exoskeleton, FES controller, or similar) that runs the Synaptiq decode engine in a clinical setting. Development licenses used in pre-clinical R&D or on test bench hardware do not count toward seat count. Lab computers running offline batch analysis on patient data do require a Clinical license.

Calibration is included in all tiers — you can run as many calibration sessions as needed per patient. The device seat license covers the full session lifecycle: initial calibration, session-to-session alignment updates, and all real-time decode events generated by that device during the license term.

Academic research institutions (universities, non-profit research centers) with IRB-approved clinical protocols can apply for a research license. Research licenses are priced at 50% of the Clinical tier rate and include access to all Clinical SDK features except the IEC 62304 documentation package. Contact [email protected] with your institution and protocol details.

Enterprise contracts are scoped per OEM. Typical inclusions: on-premise deployment of the decode engine (no cloud dependency for latency-sensitive deployments), custom training data fine-tuning for your specific electrode cap geometry, white-label packaging of the SDK under your product name, dedicated engineering support during integration (weekly syncs), and joint documentation support for regulatory submissions. Pricing depends on device volume and integration complexity.

Yes — the Development tier is specifically designed for pre-commitment evaluation. It includes the core decode pipeline with the same accuracy as Clinical (the free tier does not artificially limit performance). The only limitations are the 1-device connection cap and absence of the C++ SDK and IEC 62304 documentation. Development licenses have no time limit — evaluate at your own pace before committing to a Clinical contract.